NR4A1 and cancer: In acute myeloid leukemia, DDA also partly activates LXR to increase NR4A1, further inhibiting the expression level of cholesterol biosynthesizing enzyme 3β-hydroxysterol-Δ8,7-isomerase (D8D7I), leading to cancer autophagy induction (91).